In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small ...

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Currently, there are no approved medications for treating nonmonogenic, nonsyndromic obesity in children under 12. While ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

Lexaria, a global innovator in drug delivery platforms, is reporting on its eight-week body weight results from its WEIGHT-A24-1 ong ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...